Significant Ownership of 5AM Ventures V, L.P.
- Schedule 13D/G summary
-
- Recent SEC Schedule 13D/G filings for 5AM Ventures V, L.P. focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Signature and title
- /s/ Scott M. Rocklage - By 5AM Partners V, LLC, its General Partner, By Scott M. Rocklage, Managing Member
- Location
- San Francisco, CA
Large-stake snapshot
1 fact
Manager identity
2 facts
Follow Filing Activity
Follow 5AM Ventures V, L.P. and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from 5AM Ventures V, L.P.
Significant Ownership of 5AM Ventures V, L.P.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| TRDA | ENTRADA THERAPEUTICS, INC. | Common Stock, par value $0.0001 per share | 11% | $25,485,387 | 4,123,849 | Kush Parmar | 14 Nov 2025 | ||
| Rallybio Corp | Common Stock, par value $0.0001 per share | 5.5% | 291,788 | Andrew J. Schwab | 25 Feb 2026 | ||||
| RLYB | Rallybio Corp | Common Stock, par value $0.0001 per share | 0% | $0 | 0 | 5AM Ventures V, L.P. | 04 May 2026 |
Schedules 13D/G Reported by 5AM Ventures V, L.P.:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.